Zealand Pharma A/S ZEAL
$ 17.47
0.52%
Annual report 2021
added 12-23-2023
Country |
Danmark |
IPO year |
2017 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Emmanuel Dulac Ph.D., PharmD, MBA |
Employees in the company |
329 |
Shares |
43.2 M |
Market Cap[1] |
$ 821 M |
EBITDA (LTM) |
$ -348 M |
P/E (LTM) |
- |
P/S (LTM) |
12.35 |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.